Filing Flows › Genworth Financial (GNW) › Stock forecast & fair value
Genworth Financial (GNW) stock forecast and fair value
Genworth Financial (GNW) trades at $8.83. One analyst's price target is $10.50 (+19%). Across 13 valuation methods the middle fair value is $9.15 (+4%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $2.95 | $4.61 | $5.00 | -48% |
| P/E vs peers, weighted | $4.40 | $5.22 | $7.07 | -41% |
| P/E vs peers, matched | $1.61 | $3.50 | $4.99 | -60% |
| P/E vs peers, growth-adjusted | $1.94 | $2.90 | $4.33 | -67% |
| Residual income | $17.18 | $17.83 | $18.52 | +102% |
| P/B vs ROE (insurer peers) | $0.00 | $32.66 | $66.13 | +270% |
| Analysts' price targets | $10.50 | $10.50 | $10.50 | +19% |
| Shareholder yield (dividends + buybacks) | $9.60 | $11.20 | $13.43 | +27% |
| Stage-weighted value (financial (bank / insurer)) | $7.78 | $22.30 | $36.99 | +152% |
| Combined forecast (3 months) | $7.20 | $9.15 | $11.35 | +4% |
Genworth Financial's latest quarter
Genworth Financial, Q3 2026: revenue $1.8B (-7% year over year), operating margin -0.1%, net loss $11.0M, operating cash flow $100M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for GNW stock?
One analyst's 12-month target is $10.50, +19% from $8.83. The average rating is none.
What is Genworth Financial's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $2.24 and $32.66, with a middle value of $9.15 against a price of $8.83. Each method's assumptions are on the page.
Does Genworth Financial usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is GNW stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.